These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36346683)

  • 1. Measuring Health-Related Quality of Life in Thyroid Eye Disease.
    Sharma A; Stan MN; Rootman DB
    J Clin Endocrinol Metab; 2022 Aug; 107(Suppl_1):S27-S35. PubMed ID: 36346683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing the usefulness of the GO-QOL in a UK hospital-treated population with thyroid eye disease in the CIRTED trial.
    Dietrich A; Taylor P; White P; Wilson V; Uddin J; Lee RWJ; Dayan C; Jackson S;
    Psychol Health Med; 2018; 23(sup1):1341-1355. PubMed ID: 30092670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in thyroid eye disease: impact of quality of care.
    Estcourt S; Quinn AG; Vaidya B
    Eur J Endocrinol; 2011 May; 164(5):649-55. PubMed ID: 21367964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How patients experience thyroid eye disease.
    Smith TJ; Hegedüs L; Lesser I; Perros P; Dorris K; Kinrade M; Troy-Ott P; Wuerth L; Nori M
    Front Endocrinol (Lausanne); 2023; 14():1283374. PubMed ID: 38027128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and responsiveness of the patient-reported TED-QOL to rehabilitative surgery in thyroid eye disease.
    Fayers T; Fayers PM; Dolman PJ
    Orbit; 2016 Dec; 35(6):328-334. PubMed ID: 27599688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of thyroid eye disease: quality-of-life questionnaire (TED-QOL) in Korean patients.
    Son BJ; Lee SY; Yoon JS
    Can J Ophthalmol; 2014 Apr; 49(2):167-73. PubMed ID: 24767223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity and reliability of the TED-QOL: a new three-item questionnaire to assess quality of life in thyroid eye disease.
    Fayers T; Dolman PJ
    Br J Ophthalmol; 2011 Dec; 95(12):1670-4. PubMed ID: 21951566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging and Validation of the Specific Graves Ophthalmopathy Quality of Life Questionnaire With Health State Utility Values.
    Smith TJ; Cockerham K; Barretto N; Hirst A; Oliver L; Enstone A; Brandolini G; Taylor SD; Holt RJ
    Endocr Pract; 2024 May; 30(5):470-475. PubMed ID: 38341128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Psychosocial and Clinical Outcomes of Orbital Decompression Surgery for Thyroid Eye Disease and Predictors of Change in Quality of Life.
    Wickwar S; McBain H; Ezra DG; Hirani SP; Rose GE; Newman SP
    Ophthalmology; 2015 Dec; 122(12):2568-76.e1. PubMed ID: 26421706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States.
    Cockerham KP; Padnick-Silver L; Stuertz N; Francis-Sedlak M; Holt RJ
    Ophthalmol Ther; 2021 Dec; 10(4):975-987. PubMed ID: 34478126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.
    Edmunds MR; Boelaert K
    Thyroid; 2019 Apr; 29(4):557-562. PubMed ID: 30688164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life of patients with thyroid eye disease: 3-year follow-up in a multidisciplinary clinic in Israel.
    Zloto O; Sagiv O; Priel A; Cukierman-Yaffe T; Tirosh A; Agmon-Levin N; Madgar S; Serlin T; Ben Simon G
    Graefes Arch Clin Exp Ophthalmol; 2021 Jul; 259(7):2009-2015. PubMed ID: 33528651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility Assessment of Moderate to Severe Thyroid Eye Disease Health States.
    Smith TJ; Cockerham K; Lelli G; Choudhary C; Taylor S; Barretto N; Enstone A; Oliver L; Lynch J; Holt RJ
    JAMA Ophthalmol; 2023 Feb; 141(2):159-166. PubMed ID: 36580313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the clinical and molecular basis of thyroid orbitopathy: a review of recent evidence.
    Nivean PD; Madhivanan N; Kumaramanikavel G; Berendschot TTJM; Webers CAB; Paridaens D
    Hormones (Athens); 2024 Mar; 23(1):25-34. PubMed ID: 37910311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician-Perceived Impact of Thyroid Eye Disease on Patient Quality of Life in the United States.
    Wang Y; Sharma A; Padnick-Silver L; Francis-Sedlak M; Holt RJ; Foley C; Massry G; Douglas RS
    Ophthalmol Ther; 2021 Mar; 10(1):75-87. PubMed ID: 33196932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease.
    Vargason CW; Chelnis JG; Barahimi BI; Mawn LA
    Semin Ophthalmol; 2016; 31(4):409-14. PubMed ID: 27385363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 'Real Life' Service Evaluation Model for Multidisciplinary Thyroid Eye Services.
    Farag S; Feeney C; Lee V; Nagendran S; Jain R; Aziz A; Akishar R; Bravis V; Meeran K
    Front Endocrinol (Lausanne); 2021; 12():669871. PubMed ID: 34025584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of Life in Thyroid Eye Disease: A Systematic Review.
    Lee THB; Sundar G
    Ophthalmic Plast Reconstr Surg; 2020; 36(2):118-126. PubMed ID: 31567783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Objective and subjective outcomes of strabismus surgery in Graves' orbitopathy: a prospective multicentre study.
    Jellema HM; Saeed P; Mombaerts I; Dolman PJ; Garrity J; Kazim M; Dhrami-Gavazi E; Lyons C; Nieuwkerk P; Mourits MP
    Acta Ophthalmol; 2017 Jun; 95(4):386-391. PubMed ID: 28133945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future Projections in Thyroid Eye Disease.
    Barbesino G; Salvi M; Freitag SK
    J Clin Endocrinol Metab; 2022 Aug; 107(Suppl_1):S47-S56. PubMed ID: 36346684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.